Qiu R G, Chen J, Kirn D, McCormick F, Symons M
Onyx Pharmaceuticals, Richmond, California 94806, USA.
Nature. 1995 Mar 30;374(6521):457-9. doi: 10.1038/374457a0.
The GTPase Rac1 is a key component in the reorganization of the actin cytoskeleton that is induced by growth factors or oncogenic Ras1. Here we investigate the role of Rac1 in cell transformation and show that Rat1 fibroblasts expressing activated Val-12 Rac1 (Rac1 with valine at residue 12) display all the hallmarks of malignant transformation. In a focus-forming assay in NIH3T3 fibroblasts to measure the efficiency of transformation, we found that dominant-negative Asn-17 Rac1 inhibited focus formation by oncogenic Ras, but not by RafCAAX, a Raf kinase targeted to the plasma membrane by virtue of the addition of a carboxyterminal localization signal from K-Ras. This indicates that Rac is essential for transformation by Ras. In addition, Val-12 Rac1 synergizes strongly with RafCAAX in focus-formation assays, indicating that oncogenic Ras drives both the Rac and MAP-kinase pathways, which cooperate to cause transformation.
GTP酶Rac1是由生长因子或致癌性Ras1诱导的肌动蛋白细胞骨架重组中的关键成分。在此,我们研究了Rac1在细胞转化中的作用,并表明表达活化型Val-12 Rac1(第12位残基为缬氨酸的Rac1)的Rat1成纤维细胞表现出恶性转化的所有特征。在NIH3T3成纤维细胞的集落形成试验中以测量转化效率时,我们发现显性负性Asn-17 Rac1抑制致癌性Ras诱导的集落形成,但不抑制RafCAAX诱导的集落形成,RafCAAX是一种通过添加来自K-Ras的羧基末端定位信号而靶向质膜的Raf激酶。这表明Rac对于Ras诱导的转化至关重要。此外,在集落形成试验中,Val-12 Rac1与RafCAAX强烈协同作用,表明致癌性Ras驱动Rac和丝裂原活化蛋白激酶(MAP)途径,二者协同导致转化。